Brochure
25 Sep 2020
Supporting Your COVID-19 Therapy Development
PDF 1.5 MB
Healthcare and pharmaceutical development are at the forefront of the COVID-19 crisis as we know it. The BASF Pharma Solutions team is actively engaged in supporting the COVID-19 therapy developments of our customers in a comprehensive way.
Content provided by our supplier
BASF SE
-
DE -
2015On CPHI since
-
5000+Employees
Company types
.jpg)
Other Content from BASF SE (3)
-
Brochure BASF Pharma Solutions Product Overview
With its expertise in polymer chemistry, R&D-capabilities and its commitment in developing excipients, BASF creates solutions for Instant & Modified Release, Solubilization, Softgels, Skin-Delivery and Biologics. BASF is the leading supplier of select APIs such as ibuprofen and omega-3. -
Brochure Helping Customers Evaluate their Nitrosamine Risk Level
Nitrosamine Risk Assessments for pharmaceutical excipients are now available for instant download in RegXcellence™️. These statements provide increased transparency to our customers and help to better understand the potential for Nitrosamine formation and presence. -
Video Streamline Compliance with RegXcellence™️ from BASF Pharma Solutions
RegXcellence®️ is available online 24/7 to help customers easily navigate the complex quality and regulatory space. Customers can access a compliance document library, connect with global and regional experts, stay up to date on all documentation and requests, and more.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance